1
|
Paganini M, Pizzato M, Weinstein E, Vecchiato E, Bitetti A, Compostella C, Onesto C, Favaro A. Implementation of a nurse-led alternate care site for the management of the surge of patients with COVID-19 in an Italian emergency department. Emerg Med J 2022; 39:554-558. [PMID: 35321885 DOI: 10.1136/emermed-2021-212056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2021] [Accepted: 03/14/2022] [Indexed: 01/08/2023]
Abstract
BACKGROUND To accommodate and separate the large numbers of patients going to hospital with COVID-19, many EDs had to create new pathways for patients. We describe the outcomes of patients treated in a nurse-led alternate care site (ACS) at our hospital. METHODS This was a retrospective study of outcomes of patients managed at the ACS of 'San Bassiano' Hospital ED, Bassano del Grappa, Italy between 9 March and 16 April 2020. Self-presenting patients aged 5 years and older, suspected of having COVID-19, were initially diverted to the ACS. Patients with a National Early Warning Score ≥5 or with a desaturation ≥4% after the walking test were sent back to the main ED COVID-19 path for further evaluation and medical attention and were not further followed up. In the ACS, patients received a CXR, blood samples and a nasopharyngeal swab to test for SARS-CoV-2, and were sent home. An emergency physician reviewed the results later and called the patient back 5-6 hours later with instructions to return for medical evaluation of abnormal findings, or to seek their general practitioner's attention. Patients received a follow-up phone call 15 days later to learn of their course. RESULTS A total of 487 patients were fully managed in the ACS and discharged home. Of the 392 (80.5%) patients with no abnormalities after the workup and instructed to stay at home, 29 reattended the ED in the next 15 days, and 13 were admitted. Among the 95 patients asked to return and receive medical attention, 20 were admitted and of those discharged, 3 reattended the ED within 15 days. At 15 days, no patient was deceased or received invasive ventilation; one admitted patient received non-invasive ventilation. CONCLUSIONS A nurse-led ACS diverted a substantial proportion of patients from main ED resources without associated negative clinical outcomes.
Collapse
Affiliation(s)
- Matteo Paganini
- Department of Biomedical Sciences, Universita degli Studi di Padova, Padova, Italy .,Emergency Department, San Bassiano Hospital, ULSS7 Pedemontana, Bassano del Grappa, Italy.,Center for Research and Training in Disaster Medicine, Humanitarian Aid, and Global Health, Università degli Studi del Piemonte Orientale Amedeo Avogadro, Novara, Italy
| | - Michele Pizzato
- Emergency Department, San Bassiano Hospital, ULSS7 Pedemontana, Bassano del Grappa, Italy
| | - Eric Weinstein
- Center for Research and Training in Disaster Medicine, Humanitarian Aid, and Global Health, Università degli Studi del Piemonte Orientale Amedeo Avogadro, Novara, Italy
| | - Elena Vecchiato
- Emergency Department, San Bassiano Hospital, ULSS7 Pedemontana, Bassano del Grappa, Italy
| | - Andrea Bitetti
- Emergency Department, San Bassiano Hospital, ULSS7 Pedemontana, Bassano del Grappa, Italy
| | - Caterina Compostella
- Emergency Department, San Bassiano Hospital, ULSS7 Pedemontana, Bassano del Grappa, Italy
| | - Caterina Onesto
- Emergency Department, San Bassiano Hospital, ULSS7 Pedemontana, Bassano del Grappa, Italy
| | - Andrea Favaro
- Emergency Department, San Bassiano Hospital, ULSS7 Pedemontana, Bassano del Grappa, Italy
| |
Collapse
|
2
|
Tonon M, Da Re F, Zampieri C, Nicoletti M, Caberlotto R, De Siena FP, Lattavo G, Minnicelli A, Zardetto A, Sforzi B, Ros E, Mongillo M, Scatto A, Vecchiato E, Baldo V, Cocchio S, Russo F. Surveillance of Outbreaks of SARS-CoV-2 Infections at School in the Veneto Region: Methods and Results of the Public Health Response during the Second and Third Waves of the Pandemic between January and June 2021. Int J Environ Res Public Health 2021; 18:ijerph182212165. [PMID: 34831921 PMCID: PMC8624233 DOI: 10.3390/ijerph182212165] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/01/2021] [Revised: 11/15/2021] [Accepted: 11/17/2021] [Indexed: 12/23/2022]
Abstract
During the COVID-19 pandemic, many countries adopted various non-pharmacological interventions to contain the number of infections. The most often used policy was school closures. We describe the strategy adopted by the Veneto Regional Authority to contain transmission in school settings. This included a detailed school surveillance system, strict contact tracing, and maintaining school attendance with self-monitoring for symptoms whenever possible. All analyzed COVID-19 cases among children, adolescents (0–19 years old), and school staff were registered using a web-based application between 4 January 2021 and 13 June 2021. During the study period, 6272 episodes of infection in schools were identified; 87% were linked to a student index case and 13% to school staff; 69% generated no secondary cases; 24% generated one or two; and only 7% caused more than two. Our data may help to clarify the role of school closures, providing useful input for decisions in the months to come. Good practice in public health management needs tools that provide a real-time interpretation of phenomena like COVID-19 outbreaks. The proposed measures should be easy to adopt and accessible to policymakers.
Collapse
Affiliation(s)
- Michele Tonon
- Regional Directorate of Prevention, Food Safety, Veterinary Public Health—Regione del Veneto, 30123 Venice, Italy; (M.T.); (F.D.R.); (E.R.); (M.M.); (F.R.)
| | - Filippo Da Re
- Regional Directorate of Prevention, Food Safety, Veterinary Public Health—Regione del Veneto, 30123 Venice, Italy; (M.T.); (F.D.R.); (E.R.); (M.M.); (F.R.)
| | - Chiara Zampieri
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Michele Nicoletti
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Riccardo Caberlotto
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Francesco Paolo De Siena
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Gaia Lattavo
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Anil Minnicelli
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Alberto Zardetto
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Benedetta Sforzi
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Elisa Ros
- Regional Directorate of Prevention, Food Safety, Veterinary Public Health—Regione del Veneto, 30123 Venice, Italy; (M.T.); (F.D.R.); (E.R.); (M.M.); (F.R.)
| | - Michele Mongillo
- Regional Directorate of Prevention, Food Safety, Veterinary Public Health—Regione del Veneto, 30123 Venice, Italy; (M.T.); (F.D.R.); (E.R.); (M.M.); (F.R.)
| | - Alessandro Scatto
- Informative Systems Unit, Azienda Zero—Regione del Veneto, 35131 Padova, Italy; (A.S.); (E.V.)
| | - Elena Vecchiato
- Informative Systems Unit, Azienda Zero—Regione del Veneto, 35131 Padova, Italy; (A.S.); (E.V.)
| | - Vincenzo Baldo
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
- Correspondence:
| | - Silvia Cocchio
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy; (C.Z.); (M.N.); (R.C.); (F.P.D.S.); (G.L.); (A.M.); (A.Z.); (B.S.); (S.C.)
| | - Francesca Russo
- Regional Directorate of Prevention, Food Safety, Veterinary Public Health—Regione del Veneto, 30123 Venice, Italy; (M.T.); (F.D.R.); (E.R.); (M.M.); (F.R.)
| |
Collapse
|
3
|
Plebani M, Padoan A, Fedeli U, Schievano E, Vecchiato E, Lippi G, Lo Cascio G, Porru S, Palù G. SARS-CoV-2 serosurvey in health care workers of the Veneto Region. Clin Chem Lab Med 2020; 58:2107-2111. [PMID: 32845861 DOI: 10.1515/cclm-2020-1236] [Citation(s) in RCA: 52] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Accepted: 08/17/2020] [Indexed: 12/12/2022]
Abstract
Objectives The ongoing outbreak of coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses formidable challenges to all health care systems. Serological assays may be used for improving disease management when appropriately applied, for investigating the antibody responses mounted against SARS-CoV-2 infection and for assessing its real prevalence. Although testing the whole population is impractical, well-designed serosurveys in selected subpopulations in specific risk groups may provide valuable information. We evaluated the prevalence of SARS-CoV-2 infection in health care workers (HCW) who underwent molecular testing with reverse transcription real-time polymerase chain reaction (rRT-PCR) in the main hospitals of the Veneto Region of Italy by measuring specific antibodies (Abs). Methods Both immunoglobulin (Ig)M and IgG antibodies against SARS-Cov-2 S-antigen and N-protein were measured using a validated chemiluminescent analytical system (CLIA) called Maglumi™ 2000 Plus (New Industries Biomedical Engineering Co., Ltd [Snibe], Shenzhen, China). Results A total of 8,285 HCW were tested. SARS-CoV-2 specific antibodies (IgM, IgG or both) were detectable in 378 cases (4.6%, 95% CI 4.1-5.0%). Seroconversion was observed in 4.4% of women vs. 5.0% of men, but this difference was not significant. Although detectable antibodies were found in all HCW who developed severe COVID-19 infection (100%), lower seropositivity was found in mild disease (83%) and the lowest prevalence (58%) was observed in asymptomatic subjects. Conclusions Seroprevalence surveys are of utmost importance for understanding the rate of population that has already developed antibodies against SARS-CoV-2. The present study defined precisely the circulation of SARS-CoV-2 in a cohort of HCW in the Veneto Region, with its prevalence (4.6%) reflecting a relatively low circulation. Symptomatic individuals or those hospitalized for medical care were 100% antibody positive, whilst Abs were only detectable in 58% of asymptomatic carriers.
Collapse
Affiliation(s)
- Mario Plebani
- Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy.,Department of Medicine-DIMED, University of Padova, Padova, Italy
| | - Andrea Padoan
- Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy.,Department of Medicine-DIMED, University of Padova, Padova, Italy
| | - Ugo Fedeli
- Epidemiological Department, Azienda Zero, Veneto Region, Padova, Italy
| | - Elena Schievano
- Epidemiological Department, Azienda Zero, Veneto Region, Padova, Italy
| | - Elena Vecchiato
- Department of Information Technology, Azienda Zero, Veneto Region, Padova, Italy
| | - Giuseppe Lippi
- Section of Clinical Biochemistry, University of Verona, Verona, Italy
| | - Giuliana Lo Cascio
- Department of Microbiology and Virology, University of Verona, Verona, Italy
| | - Stefano Porru
- Department of Diagnostics and Public Health, University of Verona, Verona, Italy
| | - Giorgio Palù
- University of Padova, Azienda Zero, Veneto Region, Padova, Italy
| |
Collapse
|
4
|
Barbati G, De Domenico R, Rossi S, Vecchiato E, Zeppellini R. [Right atrial appendage thrombosis during atrial fibrillation: an element to look for]. G Ital Cardiol (Rome) 2017; 18:247-250. [PMID: 28398383 DOI: 10.1714/2674.27402] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Oral anticoagulant therapy (OAT) is a mainstay of atrial fibrillation (AF) pharmacological treatment. Left atrial appendage closure is a possible treatment, when feasible, in patients with intracerebral hemorrhage during OAT. We report a case of right atrial appendage thrombosis in a patient with chronic AF admitted for syncope due to diuretic-induced orthostatic hypotension. Two years previously, he had undergone left atrial appendage closure with the Amplatzer Cardiac Plug device because of intracerebral hemorrhage during OAT. After neurological consult, OAT was resumed with apixaban 5 mg twice daily, and transesophageal echocardiography performed two months later showed complete resolution of the right atrial appendage thrombosis. This particular case underlines the importance of searching for a possible right atrial appendage thrombosis in patients affected by AF, and suggests that left atrial appendage closure in AF patients not suitable for OAT does not fully eliminate the risk of thromboembolism.
Collapse
Affiliation(s)
- Giovanni Barbati
- S.C. Cardiologia, Ospedale San Bassiano, Bassano del Grappa (VI)
| | | | - Stefania Rossi
- S.C. Radiologia, Ospedale San Bassiano, Bassano del Grappa (VI)
| | - Elena Vecchiato
- S.C. Pronto Soccorso, Ospedale San Bassiano, Bassano del Grappa (VI)
| | | |
Collapse
|
5
|
Cristofori PG, Crivellente FA, Faustinelli I, Lanzoni AR, Lazzarini C, Vecchiato E, Andreoli M, Turton JA, Zancanaro C, Crespi FM. Involvement of the nitric oxide system in the anti-atherosclerotic potential of lacidipine in the ApoE-deficient mouse: a morphological, functional, and electrochemical study. Toxicol Pathol 2005; 32:493-9. [PMID: 15223775 DOI: 10.1080/01926230490483351] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
The present study investigated the anti-atherosclerotic activity of lacidipine, a calcium antagonist with antioxidant properties in apoE-deficient mice. These mice show widespread vascular lesions which closely resemble the inflammatory-fibrous plaques seen in humans in atherosclerosis. Mice were fed a Western-type diet (WTD), and treated for 8 weeks with either vehicle or lacidipine at 3 or 10 mg/kg/day. In parallel with histological studies of atherosclerotic lesions in the aorta, functional studies on vascular acetylcholine (ACh) reactivity and analysis of voltammetric levels of nitric oxide (NO) were performed. Recent work has suggested that dihydropyridines (DHPs) modulate vascular relaxation via an increase in the release of NO. Lacidipine treatment had no effect on the plasma lipid profile. However, a significant (p < 0.01) dose-related reduction of 36.4% and 43.3% of the aortic lesion area in respect to methocel-treated mice was observed. Moreover, the aortic ring from control apoE-deficient mice fed a WTD for 8 weeks showed a lower relaxation in response to ACh in comparison to wild-type C57BL/6J mice; on the contrary, lacidipine-treated apoE-deficient mice lacidipine-treated displayed a response similar to that of wildtype C57BL/6J mice. Voltammetric analyses demonstrated a significant decrease of NO release in apoE-deficient mice, while lacidipine-treated mice showed enhanced activity of the NO system. We conclude that lacidipine reduced the extent of atherosclerotic area in hypercholesterolemic apoE-deficient mice, and this reduction may be associated with the capacity of the drug to maintain endothelial NO levels at concentrations useful to protect against vascular damage.
Collapse
Affiliation(s)
- Patrizia G Cristofori
- Safety Assessment Department, Pathology, Glaxo Smith Kline Research Centre, Verona, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Crespi F, Vecchiato E, Lazzarini C, Andreoli M, Gaviraghi G. Evidence that lacidipine at nonsustained antihypertensive doses activates nitrogen monoxide system in the endothelium of salt-loaded Dahl-S rats. J Cardiovasc Pharmacol 2002; 39:471-7. [PMID: 11904520 DOI: 10.1097/00005344-200204000-00002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Lacidipine is a clinically active, antihypertensive calcium antagonist of the 1,4 dihydropyridine (DHP) class. It is also capable of vascular protection when administered (prophylactically and therapeutically) at nonsustained antihypertensive doses to salt-sensitive Dahl-S rats: useful animal models for studying the vasoprotective effect of calcium antagonists. In our previous work using voltammetry with selective biosensors, we observed that lacidipine implements endothelial nitrogen monoxide (NO) in normal rats. These experiments, performed in aortic rings obtained from Dahl-S rats analyzed with voltammetry and specific biosensors, further demonstrate that lacidipine, given at doses that do not control the development of hypertension (1 mg/kg), enhance endothelial NO activity. Taken together with the observation that 1 mg/kg lacidipine, and not its vehicle, is able to prevent vascular damage and concomitant increases in mortality (accelerated by a salt diet), this voltametric data suggest that NO acts as a component of positive influence of this DHP on vascular structure and function.
Collapse
Affiliation(s)
- Francesco Crespi
- Department of Biology, GlaxoSmithKline Group, GlaxoWellcome, S. p. A. Medicine Research Centre, Via Fleming 4, 37100 Verona, Italy.
| | | | | | | | | |
Collapse
|
7
|
Bianchi M, Moser C, Lazzarini C, Vecchiato E, Crespi F. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Exp Brain Res 2002; 143:191-7. [PMID: 11880895 DOI: 10.1007/s00221-001-0979-3] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2001] [Accepted: 11/13/2001] [Indexed: 11/26/2022]
Abstract
Low levels of central serotonin (5-HT) have been related to the state of depression, and 5-HT is the major target of the newer antidepressant drugs such as selective serotonin reuptake inhibitors (SSRIs). Neurons and platelets display structural and functional similarities, so that the latter have been proposed as a peripheral model of central functions. In particular, in blood more than 99% of 5-HT is contained in platelets, so that one could consider changes in 5-HT levels in platelets as a mirror of changes in central 5-HT. Here, this hypothesis has been studied via the analysis of the influence of: (1) the forced swimming test (FST, which has been proved to be of utility to predict the clinical efficacy of antidepressants in rodents) and (2) treatment with the SSRI fluoxetine upon 5-HT levels monitored in brain regions and in peripheral platelets by means of electrochemical in vivo and ex vivo measurements. The results obtained confirm that the FST increases immobility; furthermore they show a parallel and significant decrease in cerebral (brain homogenate) and peripheral (in platelet-rich plasma, PRP) voltammetric 5-HT levels following the FST in naive rats. In addition, subchronic treatment with fluoxetine was followed by a significant increase in 5-HT levels in PRP, while the same SSRI treatment performed within the FST resulted in a decrease in the 5-HT levels in PRP. However, this decrease was inferior to that observed without SSRI treatment. These data suggest that there is an inverse relationship between immobility and the levels of 5-HT in PRP and that these peripheral 5-HT levels are sensitive to: (1) the FST, (2) the treatment with fluoxetine and (3) the combination of both treatments, i.e. SSRI + FST. It has been reported that SSRI treatment at first inhibits the 5-HT transporter in brain, resulting in increased extracellular 5-HT, while following sustained SSRI treatments decreased intracellular levels of central 5-HT were observed. Accordingly, the present data show that the initial block of 5-HT reuptake is revealed by the selective increase in 5-HT levels (extracellular content) measured in PRP (not in insulated platelets, IPs) the 1st day of fluoxetine treatment. The initial action of this SSRI upon the 5-HT transporter in brain has also been confirmed by in vivo voltammetric data showing selective increase in the serotonergic signal following local injection of fluoxetine into the brain region studied. Successively, the major effect monitored is a decrease in 5-HT levels, which is more evident in IPs than in PRP. However, it is known that following 2 weeks treatment with an SSRI, 5-HT autoreceptors are desensitized and the serotonin synthesis is restored, together with the intracellular 5-HT levels. The present data showing that the levels of 5-HT in IPs tend to return to control values 12 days after the beginning of chronic fluoxetine treatment suggest that 5-HT levels in IPs (intracellular environment) mirror the influence of SSRI treatment upon the central 5-HT system. On the other hand, at day 12 of the chronic fluoxetine treatment, 5-HT content remains low in PRP. Similarly, low levels of 5-HT have been monitored in brain homogenate of rats chronically treated with fluoxetine. This would support the similarity between PRP preparation and brain homogenate as in both cases cells are disrupted by sample preparation. In conclusion this work supports the literature in proposing platelets as a peripheral model of central functions. In particular, the present data support the idea that peripheral 5-HT platelet levels can reflect the state of the central 5-HT system in conditions of depression. Furthermore, the main outcome of this study is that PRP may mirror central extracellular 5-HT levels, whilst IPs mirror neuronal 5-HT changes.
Collapse
Affiliation(s)
- M Bianchi
- Department of Biology, GlaxoSmithKline Group, GlaxoWellcome, SpA Medicine Research Centre, Via Fleming 4, 37100 Verona, Italy
| | | | | | | | | |
Collapse
|
8
|
Abstract
Dihidropyridines (DHPs) such as amlodipine, lercanidipine and lacidipine, are compounds capable of vascular protection via their calcium antagonist activity. In addition, they present vascular dilatation function, which has been related to an anti endothelin efficacy, particularly for lacidipine. Recent works have suggested that DHPs modulate vascular relaxation via increase in the release of nitrogen monoxide (NO). Using voltammetry with selective biosensors the present experiments performed in rat aortic rings demonstrate the capability of DHPs to implement endothelial NO at 'useful' and not toxic nanomolar levels, with a maximum efficacy for lacidipine. This activity joins the already described positive effects of these compounds upon vascular functions.
Collapse
Affiliation(s)
- F Crespi
- Department of Biology, GlaxoWellcome S.p.A., Medicine Research Centre, Via A. Fleming 4, 37135, Verona, Italy.
| | | | | | | |
Collapse
|
9
|
Crespi F, Lazzarini C, Andreoli M, Vecchiato E. Voltammetric and functional evidence that N-methyl-D-aspartate and substance P mediate rat vascular relaxation via nitrogen monoxide release. Neurosci Lett 2000; 287:219-22. [PMID: 10863034 DOI: 10.1016/s0304-3940(00)01174-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
It is known that substance P acts as a vasodilator via activation of the enzyme nitrogen monoxide synthase (NOS) in endothelial tissue and it is suggested that N-methyl-D-aspartate (NMDA) could stimulate nitrogen monoxide (NO) release within nervous tissue. However, the data reported concern NO metabolites (nitrites, nitrates), while there is no clear evidence to date of the action of the latter compound within the aortic tissue. In this study, amperometry with specifically prepared carbon fiber electrodes has been applied to examine the effect of NMDA or substance P upon NO release. In particular, the data obtained confirm that NMDA can stimulate NO release in vivo, in the striatum of anaesthetized rats, and that substance P can stimulate NO release in rat aortic rings (ex vivo experiments). In addition, they indicate that NMDA also stimulates NO release in rat aortic rings. This original data has been confirmed by the observation of a vasorelaxant action of NMDA within noradrenaline precontracted aortic rings. Thus, these experiments provide the first direct evidence that NMDA can mediate vascular relaxation via NO release.
Collapse
Affiliation(s)
- F Crespi
- Department of Biology, Glaxo Wellcome S.p.A., Medicine Research Centre, Verona, Italy.
| | | | | | | |
Collapse
|